Robert Bissonnette - Innovaderm Research Inc

基本信息

Career Trajectory

Bio

Dr. Bissonnette has conducted nearly 200 studies ranging from proof-of-concept to phase III studies. As a Key Opinion Leader, he has extensive knowledge of clinical dermatology, clinical research, the dermatology market and is a great asset to our clients as he is able to offer a large perspective in the dermatology research field. He published more than 140 articles and book chapters and gives lectures on various aspects of dermatology at various national and international meetings.

Research Interests

Papers共 518 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Tissue-Resident Memory and Follicular/Peripheral Helper PD-1+ T Cells Infiltrate Lesional Skin in Atopic Dermatitis

Heena Mehta, Léane Pellerin,Manuel Rubio,Catherine Maari, Étienne S Proulx, Sharan Nischal, Vaishali R Moulton, Monica W L Leung,Robert Bissonnette,Marika Sarfati

European journal of immunologyno. 6 (2025): e51820-e51820

Cited0Views0WOSBibtex

Long-term Safety and Efficacy of Delgocitinib Cream for Up to 52 Weeks in Adults with Chronic Hand Eczema: Results of the Phase 3 Open-Label Extension DELTA 3 Trial Following the DELTA 1 and 2 Trials

Melinda Gooderham,Sonja Molin,Robert Bissonnette,Margitta Worm, Marie-Noëlle Crépy,Luca Stingeni,Richard B Warren,Sibylle Schliemann,Marie-Louise Schuttelaar,Silvia Ferrucci,Esther Serra-Baldrich,Jonathan I Silverberg, Cherry Lou Balita-Crisostomo, Marie Louise Oesterdal,Ursula Plohberger,Tove Agner

Journal of the American Academy of Dermatology (2025)

Cited0Views0WOSBibtex

Reflections on Chronic Hand Eczema – Authors' Reply

Robert Bissonnette,Richard B Warren,Andreas Pinter,Tove Agner,Melinda Gooderham,Marie L A Schuttelaar, Marie-Noëlle Crépy,Luca Stingeni,Esther Serra-Baldrich, Keith Baranowski, Sofie Korn, Merle Kurvits, Ursula Plohberger, Natacha Strange Vest,Sibylle Schliemann

sciencedirect（2025）

Cited0Views0WOSBibtex

Systemic Exposure and Bioavailability of Delgocitinib Cream in Adults with Moderate to Severe Chronic Hand Eczema

Diamant Thaçi,Melinda Gooderham,Paola Lovato, Daniel Elenius Madsen, Anders Soehoel,Robert Bissonnette

Journal of the European Academy of Dermatology and Venereology JEADV (2025)

Cited0Views0WOSBibtex

ROCKET: a Phase 3 Program Evaluating the Efficacy and Safety of Rocatinlimab in Moderate-to-severe Atopic Dermatitis

Emma Guttman-Yassky,Eric Simpson,Robert Bissonnette,Lawrence F Eichenfield,Kenji Kabashima,Paula C Luna, Janá Tresnak Hercogová,Lynda Spelman,Margitta Worm,Ehsanollah Esfandiari, Takahiro Arai, Hirotaka Mano, Prista Charuworn,Andrea Wang, Gregory Kricorian

Immunotherapyno. 2 (2025): 83-94

Cited0Views0WOSBibtex

Rapid Onset of Itch Relief with Tapinarof in Two Phase 3 Trials in Atopic Dermatitis

Eric L Simpson, Jonathan I Silverberg,Robert Bissonnette,Linda Stein Gold,April Armstrong,Adelaide A Hebert, Rocco T Serrao, Jeannette R Jakus, Philip M Brown,David S Rubenstein, Stephen C Piscitelli,Anna M Tallman, Lawrence F Eichenfield

Journal of drugs in dermatology JDDno. 6 (2025): 600-607

Cited0Views0WOSBibtex

Dupilumab Treatment Restores Lesional and Non-Lesional Skin Barrier Function in Adults and Adolescents with Atopic Dermatitis Irrespective of the Filaggrin Genotype: Results from an Open-Label, Healthy-Control–matched, Phase 4 Clinical Study (BALISTAD)

Robert Bissonnette,Elena Goleva,Evgeny Berdyshev,Shannon Garcia,Marco Ramirez-Gama, Patricia A. Taylor,Gabriel Bologna, Amy H. Praestgaard, Lei Chen,Noah A. Levit,Joseph Zahn,Ana B. Rossi,Annie Zhang,Donald Y.M. Leung

Journal of the American Academy of Dermatology (2025)

Cited0Views0WOSBibtex

A Maximum-Use Trial of Ruxolitinib Cream in Children Aged 2–11 Years with Moderate to Severe Atopic Dermatitis

Linda Stein Gold,Robert Bissonnette,Seth Forman,Andrea Zaenglein,YuTzu Kuo,Brett Angel,Xuejun Chen,Howard Kallender,Amy S. Paller

American Journal of Clinical Dermatologypp.1-15, (2025)

Cited0Views0WOSBibtex

Skin Tape Stripping Reveals Distinct Biomarker Profiles in Chronic Hand Eczema of Patients with and Without Comorbid Atopic Dermatitis

Jonathan Bar,Ester Del Duca,Eden David,Swaroop Bose, Gabriella Chefitz,Patrick M. Brunner,Robert Bissonnette,Emma Guttman-Yassky

ALLERGY（2025）

Cited0Views0WOSBibtex

Skin Clearance, Duration of Treatment-Free Interval, and Safety of Tapinarof Cream 1% Once Daily: Results from ADORING 3, a 48-Week Phase 3 Open-Label Extension Trial in Adults and Children Down to 2 Years of Age with Atopic Dermatitis

Robert Bissonnette,Linda Stein Gold,Leon Kircik, Eric L Simpson, Lawrence F Eichenfield, John Browning,Adelaide A Hebert,Andrew F Alexis,Weily Soong, Stephen C Piscitelli,Anna M Tallman,David S Rubenstein, Philip M Brown, Jonathan I Silverberg

Journal of the American Academy of Dermatology (2025)

Cited0Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn